Safety profile of belatacept in a real-life setting: disproportionality analysis of the WHO pharmacovigilance database
Abstract Background Belatacept is a co-stimulation blocker used in kidney transplant recipients to prevent allograft rejection. Unlike calcineurin inhibitors, belatacept is non-nephrotoxic and may carry a lower risk of cardiovascular and metabolic complications. However, the European Medicines Agenc...
Guardado en:
| Autores principales: | , , , , , , , , |
|---|---|
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
BMC
2025-08-01
|
| Colección: | BMC Pharmacology and Toxicology |
| Materias: | |
| Acceso en línea: | https://doi.org/10.1186/s40360-025-00972-6 |
| Etiquetas: |
Sin Etiquetas, Sea el primero en etiquetar este registro!
|